Predicting breast cancer drug response by 20/20 GeneSystems’ PredicTOR test
20/20 GeneSystems, Inc. will present results this week at the Breast Cancer Symposium 2012 (San Francisco) of a 45 patient study showing the usefulness of its PredicTOR test in predicting response of breast tumors to the drug Herceptin.
Linear Mode
